SPOTLIGHT -
Alcon Laboratories announced the results of two clinical studies on itsfourth-generation fluoroquinolone moxifloxacin (Vigamox). The results werepresented in a Monday morning poster session.
Bausch + Lomb announces results from a clinical study of a novel daily nutritional supplement for dry eyes
(EyePod) From idea to impact: Navigating ophthalmic innovation
The Fred Hollows Foundation supporting 2030 IN SIGHT LIVE
EyePod: Modifier Gene Therapy: What is it?
Verana Health launches its Qdata Thyroid Eye Disease module
Gene editing untangles one strand of the AMD web